Cite
A selective reversible azapeptide inhibitor of human neutrophil proteinase 3 derived from a high affinity FRET substrate
MLA
Epinette, Christophe, et al. “A Selective Reversible Azapeptide Inhibitor of Human Neutrophil Proteinase 3 Derived from a High Affinity FRET Substrate.” Biochemical Pharmacology, vol. 83, no. 6, Mar. 2012, pp. 788–96. EBSCOhost, https://doi.org/10.1016/j.bcp.2011.12.023.
APA
Epinette, C., Croix, C., Jaquillard, L., Marchand-Adam, S., Kellenberger, C., Lalmanach, G., Cadene, M., Viaud-Massuard, M.-C., Gauthier, F., & Korkmaz, B. (2012). A selective reversible azapeptide inhibitor of human neutrophil proteinase 3 derived from a high affinity FRET substrate. Biochemical Pharmacology, 83(6), 788–796. https://doi.org/10.1016/j.bcp.2011.12.023
Chicago
Epinette, Christophe, Cécile Croix, Lucie Jaquillard, Sylvain Marchand-Adam, Christine Kellenberger, Gilles Lalmanach, Martine Cadene, Marie-Claude Viaud-Massuard, Francis Gauthier, and Brice Korkmaz. 2012. “A Selective Reversible Azapeptide Inhibitor of Human Neutrophil Proteinase 3 Derived from a High Affinity FRET Substrate.” Biochemical Pharmacology 83 (6): 788–96. doi:10.1016/j.bcp.2011.12.023.